Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis

BMC Immunol
24 April 2015
https://pubmed.ncbi.nlm.nih.gov/25906771/

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis

J Clin Gastroenterol
October 2015
https://www.academia.edu/28700218/Initial_Findings_of_an_Open_Label_Trial_of_Low_Dose_Naltrexone_for_Symptomatic_Mesenteric_Panniculitis

Low Dose Naltrexone (LDN): New in the treatment of chronic pain syndromes. What really matters – reduced pain or increased energy?

Neuro Sciences
15 October 2015
https://www.jns-journal.com/article/S0022-510X(15)01775-X/fulltext

No Antagonists for an Antagonist: One Pitfall of Chronic Oral Low-Dose Naltrexone

Pain Medicine
December 2015
http://www.painmedicinenews.com/download/Casespmnse1215_WM.pdf

A 48 year old man with 10 years of chronic abdominal pain following an open repair of an abdominal aortic aneurysm was treated with low dose naltrexone 1.5mg/day for 3 years with satisfactory results.

Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy

Pain Medicine
April 2016
http://painmedicine.oxfordjournals.org/content/early/2015/11/25/pm.pnv009

A novel glial cell inhibitor, low dose naltrexone, reduces pain and depression, and improves function in chronic pain: A CHOIR study

J Pain
01 April 2016
http://www.jpain.org/article/S1526-5900(16)00425-9/fulltext

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients

Int J Pharm Compd
May-June 2016
https://www.ncbi.nlm.nih.gov/pubmed/28333660

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

J Affect Disor
15 January 2017
https://www.ncbi.nlm.nih.gov/pubmed/27736689

Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database

Pharmacoepidemiol Drug Saf
June 2017
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485080/

Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use

Am J Emerg Med
August 2017
https://pubmed.ncbi.nlm.nih.gov/28410920/